VCFix is the first vertebral fracture system that doesn’t rely on bone cement. Its 3D-printed structure stimulates bone ingrowth and provides stability of loads in the spine, the company said.
A breakthrough designation is granted to technologies that have the potential to provide more effective treatments for certain conditions. It gives companies direct communication with the FDA as well as priority review.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.